Thymoma-associated myasthenia gravis: Outcome, clinical and pathological correlations in 197 patients on a 20-year experience

Journal of Neuroimmunology

Volumn 201-202, Issue C, 2008, Pages 237-244

  Maggi, Lorenzo ^a   Andreetta, Francesca ^a   Antozzi, Carlo ^a   Baggi, Fulvio ^a   Bernasconi, Pia ^a   Cavalcante, Paola ^a   Cornelio, Ferdinando ^a   Muscolino, Giuseppe ^b   Novellino, Lorenzo ^c   Mantegazza, Renato ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b Humanitas Gavazzeni Hospital   (Italy)

^c Policlinico S Pietro   (Italy)

Author keywords

Myasthenia gravis; Thymoma; Thymomectomy; VATET

Indexed keywords

AZATHIOPRINE; CHOLINESTERASE INHIBITOR; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID;

ADULT; ARTICLE; CANCER RECURRENCE; CANCER REGRESSION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIFE TABLE; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; OUTCOME ASSESSMENT; PLASMAPHERESIS; PRIORITY JOURNAL; RISK ASSESSMENT; THYMECTOMY; THYMOMA; VIDEORECORDING;

ADULT; AGE FACTORS; CHOLINESTERASE INHIBITORS; FEMALE; HUMANS; LIFE TABLES; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THYMECTOMY; THYMOMA; THYMUS NEOPLASMS; TREATMENT OUTCOME; VIDEO-ASSISTED SURGERY;

EID: 51849100206     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2008.07.012     Document Type: Article

References (40)

1. Aarli J.A. Late-onset myasthenia gravis: a changing scene. Arch. Neurol. 56 (1999) 25-27
2. Beeson D., Jacobson L., Newsom-Davis J., and Vincent A. A transfected human muscle cell line expressing the adult subtype of the human muscle acetylcholine receptor for diagnostic assays in myasthenia gravis. Neurology 47 (1996) 1552-1555
3. Budde J.M., Morris C.D., Gal A.A., Mansour K.A., and Miller Jr. J.I. Predictors of outcome in thymectomy for myasthenia gravis. Ann. Thorac. Surg. 72 (2001) 197-202
4. Calhoun R.F., Ritter J.H., Guthrie T., Pestronk A., Meyers B.F., Patterson G.A., Pohl M.S., and Cooper J.D. Results of transcervical thymectomy for myasthenia gravis in 100 consecutive patients. Ann. Surg. 230 (1999) 555-559
5. Chen G., Marx A., Wen-Hu C., Yong J., Puppe B., Stroebel P., and Müller-Hermelink H.K. New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China. Cancer 95 (2002) 420-429
6. Cosi V., Romani A., Lombardi M., Raiola E., Bergamaschi R., Piccolo G., Citterio A., and Berzuini C. Prognosis of myasthenia gravis: a retrospective study of 380 patients. J. Neurol. 244 (1997) 548-555
7. Detterbeck F.C. Clinical value of the WHO classification system of thymoma. Ann. Thorac. Surg. 81 (2006) 2328-2334
8. Drachman D.B. Myasthenia gravis. N. Engl. J. Med. 330 (1994) 1797-1810
9. Durelli L., Maggi G., Casadio C., Ferri R., Rendine S., and Bergamini L. Actuarial analysis of the occurrence of remission following thymectomy for myasthenia gravis in 400 patients. J. Neurol. Neurosurg. Psychiatry 54 (1991) 406-411
10. Evoli A., Minisci C., Di Schino C., Marsili F., Punzi C., Batocchi A.P., Tonali P.A., Doglietto G.B., Granone P., Trodella L., Cassano A., and Lauriola L. Thymoma in patients with MG: characteristics and long-term outcome. Neurology 59 (2002) 1844-1850
11. Gautel M., Lakey A., Barlow D.P., Holmes Z., Scales S., Leonard K., Labeit S., Mygland Å., Gilhus N.E., and Aarli J.A. Titin autoantibodies in myasthenia gravis: identification of a major immunogenic region of titin. Neurology 43 (1993) 1581-1585
12. Grob D., Arsura E.L., Brunner N.G., and Namba T. The course of myasthenia gravis and therapies affecting outcome. Ann. N. Y. Acad. Sci. 505 (1987) 472-479
13. Huang C.S., Hsu H.S., Huang B.S., Lee H.C., Kao K.P., Hsu W.H., and Huang M.H. Factors influencing the outcome of transsternal thymectomy for myasthenia gravis. Acta Neurol. Scand. 112 (2005) 108-114
14. Jaretzki III A., Penn A.S., and Younger D.S. "Maximal" thymectomy for myasthenia gravis. Results. J. Thorac. Cardiovasc. Surg 95 (1988) 747-757
15. Jaretzki III A., Barohn R.J., Raina M.E., Kaminski H.J., Keesey J.C., Penn A.S., and Sanders D.B. Myasthenia gravis. Recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology 55 (2000) 16-23
16. Kim H.K., Park M.S., Choi Y.S., Kim K., Shim Y.M., Han J., Kim B.J., and Kim J. Neurological outcomes of thymectomy in myasthenia gravis: comparative analysis of the effect of thymoma. J. Thorac. Cardiovasc. Surg. 134 (2007) 601-607
17. Kondo K., and Monden Y. Thymoma and myasthenia gravis: a clinical study of 1,089 patients from Japan. Ann. Thorac. Surg. 79 (2005) 219-224
18. Lindstrom J.M., Engel A.G., Seybold M.E., Lennon V.A., and Lambert E.H. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine receptors antibodies. J. Exp. Med. 144 (1976) 739-753
19. Lopez-Cano M., Ponseti-Bosch J.M., Espin-Basany E., Sanchez-Garcia J.L., and Armengol-Carrasco M. Clinical and pathologic predictors of outcome in thymoma-associated myasthenia gravis. Ann. Thorac. Surg. 76 (2003) 1643-1649
20. Maggi G., Casadio C., Cavallo A., Cianci R., Molinatti M., and Ruffini E. Thymectomy in myasthenia gravis. Results of 662 cases operated upon in 15 years. Eur. J. Cardio-thorac. Surg. 3 (1989) 504-511
21. Mantegazza R., Antozzi C., Pelucchetti D., Sghirlanzoni A., and Cornelio F. Azathioprine as a single drug or in combination with steroids in the treatment of myasthenia gravis. J. Neurol. 235 (1988) 449-453
22. Mantegazza R., Beghi E., Pareyson D., Antozzi C., Peluchetti D., Sghirlanzoni A., Cosi V., Lombardi M., Piccolo G., Tonali P., Evoli A., Ricci E., Batocchi A.P., Angelini C., Micaglio G.F., Marconi G., Taiuti R., Bergamini L., Durelli L., and Cornelio F. A multicentre follow-up study of 1152 patients with myasthenia gravis in Italy. J. Neurol. 237 (1990) 339-344
23. Mantegazza R., Baggi F., Bernasconi P., Antozzi C., Confalonieri P., Novellino L., Spinelli L., Ferrò M.T., Beghi E., and Cornelio F. Video-assisted thoracoscopic extended thymectomy and extended transsternal thymectomy(T-3b) in non-thymomatous myasthenia gravis patients: remission after 6 years of follow-up. J. Neurol. Sci. 212 (2003) 31-36
24. Masaoka A., Monden Y., Nakahara K., and Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer 48 (1981) 2485-2492
25. Masaoka A., Yamakawa Y., Niwa H., Fukai I., Kondo S., Kobayashi M., Fujii Y., and Monden Y. Extended thymectomy for myasthenia gravis patients: a 20-year review. Ann. Thorac. Surg. 62 (1996) 853-859
26. Monden Y., Nakahara K., Nanjo S., Fujii Y., Matsumura A., Masaoka A., and Kawashima Y. Invasive thymoma with myasthenia gravis. Cancer 54 (1984) 2513-2518
27. Monden Y., Nakahara K., Iioka S., Nanjo S., Ohno K., Fujii Y., Hashimoto J., Kitagawa Y., Masaoka A., and Kawashima Y. Recurrence of thymoma: clinicopathological features, therapy, and prognosis. Ann. Thorac. Surg. 39 (1985) 165-169
28. Müller-Hermelink H.K., Engel P., Kuo T.T., Ströbel P., Marx A., Harris N.L., Moller P., Menestrina F., Shimosato Y., Asamura H., Masaoka A., and Sobin L.H. Tumours of the thymus. In: Travis W.D., Brambilla E., Müller-Hermelink H.K., and Harris C.C. (Eds). Pathology and genetics of tumours of the lung, pleura, thymus, and heart, World Health Organization Classification of Tumors (2004), IARC press, Lyon 146-171
29. Mygland Å., Tysnes O.B., Aarli J.A., Flood P.R., and Gilhus N.E. Myasthenia gravis patients with a thymoma have antibodies against a high molecular weight protein in sarcoplasmic reticulum. J. Neuroimmunol. 37 (1992) 1-7
30. Novellino L., Longoni M., Spinelli L., Andretta M., Cozzi M., and Faillace G. "Extended" thymectomy without sternotomy performed by cervicotomy and thoracoscopic technique in the treatment of myasthenia gravis. Int. Surg. 79 (1994) 378-381
31. Oger J.J. Thymus histology and acetylcholine receptor antibodies in generalized myasthenia gravis. Ann. N. Y. Acad. Sci. 681 (1993) 110-112
32. Okumura M., Ohta M., Tateyama H., Nakagawa K., Matsumura A., Maeda H., Tada H., Eimoto T., Matsuda H., and Masaoka A. The World Health Organization histologic classification system reflects the oncologic behaviour of thymoma: a clinical study of 273 patients. Cancer 94 (2002) 624-632
33. Okumura M., Shiono H., Minami M., Inoue M., Utsumi T., Kadota Y., and Sawa Y. Clinical and pathological aspects of thymic epithelial tumors. Gen. Thorac. Cardiovasc. Surg. 56 (2008) 10-16
34. Oosterhuis H.J. The natural course of myasthenia gravis: a long term follow-up study. J. Neurol. Neurosurg. Psychiatry 52 (1989) 1121-1127
35. Papatestas A.E., Genkins G., Kornfeld P., Eisenkraft J.B., Fagerstrom R.P., Pozner J., and Aufses Jr. A.H. Effects of thymectomy in myasthenia gravis. Ann. Surg. 206 (1987) 79-88
36. Romi F., Gilhus N.E., Varhaug J.E., Myking A., and Aarli J.A. Disease severity and outcome in thymoma myasthenia gravis: a long-term observation study. Eur. J. Neurol. 10 (2003) 701-706
37. Rosai J., and Sobin L.H. Histological typing of tumors of the thymus. World Health Organization, International Histological Classification of Tumors. 2nd ed (1999), Springer, New York 9-14
38. Ströbel P., Bauer A., Puppe B., Kraushaar T., Krein A., Toyka K., Gold R., Semik M., Kiefer R., Nix W., Schalke B., Müller-Hermelink H.K., and Marx A. Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis. J. Clin. Oncol. 22 (2004) 1501-1509
39. Tsinzerling N., Lefvert A.K., Matell G., and Pirskanen-Matell R. Myasthenia gravis: a long term follow-up study of Swedish patients with specific reference to thymic histology. J. Neurol. Neursurg. Psychiatry. 78 (2007) 1109-1112
40. Venuta F., Rendina E.A., De Giacomo T., Della Rocca G., Antonini G., Ciccone A.M., Ricci C., and Coloni G.F. Thymectomy for myasthenia gravis: a 27-year experience. Eur. J. Cardiothorac. Surg. 5 (1999) 621-624